Table 2.
Echocardiographic parameters
| Con | TP | DM | DM + TP,L | DM + TP,M | DM + TP,H | |
|---|---|---|---|---|---|---|
| LVEDD, mm |
6.5 ± 0.5 |
6.6 ± 0.5 |
5.7 ± 0.8 |
5.9 ± 0.4 |
5.5 ± 0.7 |
5.3 ± 1.1 |
| LVEDD index, um/g |
14.3 ± 1.2 |
14.4 ± 1.1 |
23.9 ± 3.4* |
22.0 ± 2.9* |
22.2 ± 2.1* |
21.1 ± 4.6* |
| LVESD, mm |
3.8 ± 0.3 |
3.8 ± 0.4 |
3.8 ± 0.6 |
3.7 ± 0.3 |
3.2 ± 0.3 |
3.2 ± 0.9 |
| LVESD index, um/g |
8.3 ± 0.7 |
8.2 ± 0.9 |
16.0 ± 2.5* |
13.7 ± 2.2* |
13.0 ± 1.1 |
12.6 ± 3.4 |
| LVEF,% |
78.2 ± 2.6 |
77.5 ± 3.1 |
67.8 ± 2.6* |
73.7 ± 2.5 |
74.8 ± 3.8# |
74.4 ± 3.8# |
| FS,% | 43.2 ± 2.6 | 42.7 ± 3.3 | 35.0 ± 1.6* | 39.5 ± 2.4 | 40.8 ± 3.3 | 40.0 ± 3.7 |
LVEDD left ventricular end-diastolic dimension, LVESD left ventricular end-systolic dimension, LVEF left ventricular ejection fraction, FS fractional shortening. TP, L low-dose triptolide (100 μg/kg/day), TP, M medium-dose triptolide (200 μg/kg/day); TP, H high-dose triptolide (400 μg/kg/day). *P < 0.05 versus Con; #P < 0.05 versus DM.